AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

The Role of Procalcitonin (PCT) and other Biomarkers to aid in the Differential Diagnosis and Management of Bacterial Infectious Diseases

  • Credit:1.0 ACCENT Credits
  • Duration: 1 Hour
  • Date:JUN.11.2020 1:00 PM - 02:00 PM

Price: $0.00

Member Price: $0.00

DESCRIPTION

Biomarkers such as procalcitonin (PCT) can further guide prognosis of bacterial sepsis, assessment of mortality risk, and duration of antibiotic therapy. Join Stefan Riedel, MD, PhD, as he shares his working knowledge of the utility of procalcitonin and other biomarkers in diagnosing and managing sepsis and other bacterial infections, such as bacterial pneumonia. In this presentation Riedel will also explore analytical and clinical considerations of PCT.

WHAT YOU WILL LEARN:

  • How to describe the biology & kinetics of procalcitonin and other biomarkers.
  • How to compare the performance characteristics of procalcitonin assays dependent on various analytical testing platforms
  • How to identify the utility of procalcitonin and other biomarkers to aid in the differential diagnosis of various infectious diseases, including bacterial sepsis and pneumonia
  • How to assess the utility of procalcitonin and other biomarkers for management of bacterial infection with focus on antimicrobial stewardship

SPEAKERS

Dr. Stefan Riedel

Stefan Riedel, MD, PhD, D(ABMM), FCAP
Associate Medical Director, Clinical Microbiology Laboratories
Beth Israel Deaconess Medical Center
Associate Professor of Pathology, Harvard Medical School
Boston, MA

 

This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID# 2001. This activity was planned in accordance with ACCENT® Standards and Policies.

Supported By

Thermo Fisher logo